Innoviva Inc (INVA)
Healthcare
Biotechnology
21.00 $
-1.2%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Innoviva Inc (INVA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 93.8% of the shares are freely tradable; institutional investors hold 108.0%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
108.0%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
1.0%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
93.8%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
12.1%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
74Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 15.32 | 11,307,845 | +5.9 | 03/31/2026 |
| Vanguard Group Inc | 10.73 | 7,917,103 | +11.6 | 12/31/2025 |
| Dimensional Fund Advisors, Inc. | 6.01 | 4,436,427 | +1.7 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 5.72 | 4,224,951 | +0.0 | 03/31/2026 |
| Renaissance Technologies Corp | 5.49 | 4,055,632 | -3.7 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.26 | 3,141,581 | +0.0 | 03/31/2026 |
| State Street Corp | 4.15 | 3,060,377 | +9.4 | 03/31/2026 |
| Millennium Management LLC | 3.09 | 2,279,451 | +41.6 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 5.83 | 4,305,053 | +0.0 | 05/29/2026 |
| Vanguard Total Stock Mkt Idx Inv | 3.02 | 2,231,526 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.